- Judges Scientific expects full-year results to be in line with current market forecasts.

A trading statement for the year ended 31 December said: "As reported at the half year, organic order intake experienced a slow start in H1.

"This was followed by an excellent third quarter and a respectable fourth quarter resulting in a 3% organic growth in order intake for the financial year.

"If Armfield (which was acquired in January 2015 and is not part of organic growth on a like-for-like basis) was included, order intake would show a 2.3% decline from 2015.

"Slow order intake at Armfield and one of Judges' organic businesses, as well as production issues at another, were only partially offset by the good performance from all of the remaining Group businesses and the contribution of the four businesses acquired in 2016.

"This will be reflected in the full year results, which the Board expects to be in line with current market expectations."

Judges said it commenced 2017 with a robust order book (13.9 weeks compared to 11.4 weeks on 1 January 2016) and a positive foreign exchange environment but with the continuing influence of some of the difficulties experienced in 2016.

At 9:30am: [LON:JDG] Judges Scientific PLC share price was -62.5p at 1465p

Story provided by